data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
RAPT Therapeutics
(NASDAQ:RAPT)
$18.45
0.38[2.10%]
Last update: 12:50PM
Day High/Low17.7 - 18.74
52 Week High/Low9.86 - 40.74
Open / Close17.77 / -
Float / Outstanding21.9M / 29.6M
Vol / Avg.125.5K / 369.6K
Mkt Cap547M
P/E-
50d Avg. Price15.21
Div / Yield-
Payout Ratio-
EPS-0.69
Total Float21.9M

RAPT Therapeutics (NASDAQ:RAPT), Quotes and News Summary

RAPT Therapeutics (NASDAQ: RAPT)

Day High/Low17.7 - 18.74
52 Week High/Low9.86 - 40.74
Open / Close17.77 / -
Float / Outstanding21.9M / 29.6M
Vol / Avg.125.5K / 369.6K
Mkt Cap547M
P/E-
50d Avg. Price15.21
Div / Yield-
Payout Ratio-
EPS-0.69
Total Float21.9M
Benzinga - Jun 23, 2022, 6:13AM
Benzinga - May 25, 2022, 3:01PM
Benzinga - May 25, 2022, 8:05AM
Benzinga - May 24, 2022, 9:55AM
Benzinga - May 23, 2022, 8:04AM
Benzinga - May 13, 2022, 11:29AM
Benzinga - May 12, 2022, 10:09AM
Benzinga - May 11, 2022, 8:05AM
Benzinga - Mar 28, 2022, 8:12AM
Benzinga - Mar 28, 2022, 8:07AM
Benzinga - Mar 11, 2022, 10:21AM
Benzinga - Mar 11, 2022, 8:06AM
Benzinga - Mar 10, 2022, 8:09AM
Benzinga - Dec 9, 2021, 6:34AM
Benzinga - Nov 10, 2021, 4:46PM
Benzinga - Oct 18, 2021, 8:13AM
Benzinga - Aug 12, 2021, 6:20AM
Sector: Health Care.Industry: Biotechnology
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-10
REV
Q1 2022Est.ActualSurprise
EPS-0.680-0.690 -0.0100
REV220.000K641.000K421.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

RAPT Therapeutics Questions & Answers

Q
How do I buy RAPT Therapeutics (RAPT) stock?
A

You can purchase shares of RAPT Therapeutics (NASDAQ: RAPT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are RAPT Therapeutics's (RAPT) competitors?
Q
What is the target price for RAPT Therapeutics (RAPT) stock?
A

The latest price target for RAPT Therapeutics (NASDAQ: RAPT) was reported by HC Wainwright & Co. on Thursday, June 23, 2022. The analyst firm set a price target for 50.00 expecting RAPT to rise to within 12 months (a possible 171.00% upside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for RAPT Therapeutics (RAPT)?
A

The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $18.45 last updated Today at July 5, 2022, 4:50 PM UTC.

Q
Does RAPT Therapeutics (RAPT) pay a dividend?
A

There are no upcoming dividends for RAPT Therapeutics.

Q
When is RAPT Therapeutics (NASDAQ:RAPT) reporting earnings?
A

RAPT Therapeutics’s Q2 earnings are confirmed for Wednesday, August 10, 2022.

Q
Is RAPT Therapeutics (RAPT) going to split?
A

There is no upcoming split for RAPT Therapeutics.

Q
What sector and industry does RAPT Therapeutics (RAPT) operate in?
A

RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.